References
Cimitan M, Bortolus R, Morassut S, Canzonieri V, Garbeglio A, Baresic T, et al. [18F]fluorocholine PET/CT imaging for the detection of recurrent prostate cancer at PSA relapse: experience in 100 consecutive patients. Eur J Nucl Med Mol Imaging 2006;33:1387–98.
Langsteger W, Heinisch M, Fogelman I. The role of fluorodeoxyglucose, 18F-dihydroxyphenylalanine, 18F-choline, and 18F-fluoride in bone imaging with emphasis on prostate and breast. Semin Nucl Med 2006;36:73–92.
Langsteger W, Beheshti M, Poecher S, Loidl W, Haim S, Stoiber F, et al. Fluor choline (FCH) positron emission tomography/computed tomography in preoperative staging and follow up of prostate cancer patients. Mol Imag Biol 2006;8(2):69.
Beheshti M, Haim S, Nader M, Poecher S, Jordanova N, Stoiber F, et al. Assessment of bone metastases in patients with prostate cancer by dual-phase F-18 fluor choline PET/CT. Eur J Nucl Med Mol Imaging 2006;33 Suppl 2:208.
Langsteger W, Beheshti M, Nader M, Stoiber F, Loidl W, Fitz F, et al. Evaluation of lymph node and bone metastases with fluor choline (FCH) PET-CT in the follow up of prostate cancer patients. Eur J Nucl Med Mol Imaging 2006;33 Suppl 2:209.
Author information
Authors and Affiliations
Corresponding author
Additional information
An authors’ reply to this letter is available at http://dx.doi.org/10.1007/s00259-007-0402-9.
Rights and permissions
About this article
Cite this article
Beheshti, M., Vali, R. & Langsteger, W. [18F]fluorocholine PET/CT in the assessment of bone metastases in prostate cancer. Eur J Nucl Med Mol Imaging 34, 1316–1317 (2007). https://doi.org/10.1007/s00259-007-0401-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00259-007-0401-x